Migraine Intervention With STARFlex Technology (MIST) Trial
Author(s) -
Andrew Dowson,
Michael Mullen,
Richard Peatfield,
Keith W. Muir,
Arif Anis Khan,
Christopher Wells,
S. Lipscombe,
T. Rees,
Joseph V. De Giovanni,
W.L. Morrison,
David HildickSmith,
Giles Elrington,
W. Stewart Hillis,
Iqbal Malik,
A F Rickards
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.727271
Subject(s) - medicine , migraine , patent foramen ovale , implant , randomized controlled trial , chronic migraine , migraine with aura , aura , clinical endpoint , anesthesia , surgery
Patent foramen ovale (PFO) is prevalent in patients with migraine with aura. Observational studies show that PFO closure resulted in migraine cessation or improvement in approximately 80% of such patients. We investigated the effects of PFO closure for migraine in a randomized, double-blind, sham-controlled trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom